Live Demonstration: An IoT Wearable Device for Real-time Blood Glucose Prediction with Edge AI

Author(s):  
Lei Kuang ◽  
Taiyu Zhu ◽  
Kezhi Li ◽  
John Daniels ◽  
Pau Herrero ◽  
...  
Author(s):  
Taiyu Zhu ◽  
Lei Kuang ◽  
John Daniels ◽  
Pau Herrero ◽  
Kezhi Li ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 778-P
Author(s):  
ZIYU LIU ◽  
CHAOFAN WANG ◽  
XUEYING ZHENG ◽  
SIHUI LUO ◽  
DAIZHI YANG ◽  
...  

Author(s):  
Muhammad Faris Roslan ◽  
◽  
Afandi Ahmad ◽  
Abbes Amira ◽  
◽  
...  

Author(s):  
Josep Maria Margarit-Taule ◽  
Pablo Gimenez-Gomez ◽  
Roger Escude-Pujol ◽  
Manuel Gutierrez-Capitan ◽  
Cecilia Jimenez-Jorquera ◽  
...  

2021 ◽  
pp. 193229682110182
Author(s):  
Aaron P. Tucker ◽  
Arthur G. Erdman ◽  
Pamela J. Schreiner ◽  
Sisi Ma ◽  
Lisa S. Chow

Successful measurements of interstitial glucose are a key component in providing effective care for patients with diabetes. Recently, there has been significant interest in using neural networks to forecast future glucose values from interstitial measurements collected by continuous glucose monitors (CGMs). While prediction accuracy continues to improve, in this work we investigated the effect of physiological sensor location on neural network blood glucose forecasting. We used clinical data from patients with Type 2 Diabetes who wore blinded FreeStyle Libre Pro CGMs (Abbott) on both their right and left arms continuously for 12 weeks. We trained patient-specific prediction algorithms to test the effect of sensor location on neural network forecasting ( N = 13, Female = 6, Male = 7). In 10 of our 13 patients, we found at least one significant ( P < .05) increase in forecasting error in algorithms which were tested with data taken from a different location than data which was used for training. These reported results were independent from other noticeable physiological differences between subjects (eg, height, age, weight, blood pressure) and independent from overall variance in the data. From these results we observe that CGM location can play a consequential role in neural network glucose prediction.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Yannian Wang ◽  
Fenfen Wei ◽  
Changqing Sun ◽  
Quanzhong Li

Diabetes may result in some complications and increase the risk of many serious health problems. The purpose of clinical treatment is to carefully manage the blood glucose concentration. If the blood glucose concentration is predicted, treatments can be taken in advance to reduce the harm to patients. For this purpose, an improved grey GM (1, 1) model is applied to predict blood glucose with a small amount of data, and especially in terms of improved smoothness it can get higher prediction accuracy. The original data of blood glucose of type 2 diabetes is acquired by CGMS. Then the prediction model is established. Finally, 50 cases of blood glucose from the Henan Province People’s Hospital are predicted in 5, 10, 15, 20, 25, and 30 minutes, respectively, in advance to verify the prediction model. The prediction result of blood glucose is evaluated by the EGA, MSE, and MAE. Particularly, the prediction results of postprandial blood glucose are presented and analyzed. The result shows that the improved grey GM (1, 1) model has excellent performance in postprandial blood glucose prediction.


Sign in / Sign up

Export Citation Format

Share Document